The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Air Methods's revenues will wane -2.5% and EPS will shrink to a loss.
The average estimate for revenue is $186.0 million. On the bottom line, the average EPS estimate is -$0.05.
Last quarter, Air Methods reported revenue of $216.2 million. GAAP reported sales were 12% higher than the prior-year quarter's $193.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.55. GAAP EPS of $0.55 for Q4 were 72% higher than the prior-year quarter's $0.32 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 40.5%, 320 basis points better than the prior-year quarter. Operating margin was 19.4%, 470 basis points better than the prior-year quarter. Net margin was 9.9%, 350 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $908.1 million. The average EPS estimate is $2.08.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 261 members out of 280 rating the stock outperform, and 19 members rating it underperform. Among 74 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 71 give Air Methods a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Air Methods is outperform, with an average price target of $42.00.
Is Air Methods the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Air Methods to My Watchlist.